Articles tagged with Vision Disorders
Researchers are testing whether low-concentrate atropine drops can delay the onset of myopia in children. The study aims to reduce the risk of sight-threatening complications later in life by decreasing how nearsighted someone becomes.
A recent study has found that people with psoriasis are at a significantly higher risk of developing AMD, including both exudative and non-exudative forms. The study suggests that biologic therapies may offer protective benefits for individuals with psoriasis.
A new study shows that laser treatment, PRK, is as safe and effective in treating myopia in older teenagers (17-18 years) as it is in adults. The procedure achieved excellent results with around 64% of teenagers' eyes achieving 20/20 vision.
A study found that more than half of the general population in the USA and Europe experience dry eyes, with only 20% of European patients and 17% of US patients receiving a diagnosis. The delay in seeking treatment is concerning, as early intervention can prevent inflammation and worsening symptoms.
Researchers developed a new treatment using specially formulated eye drops that improved near vision for patients with presbyopia. The study found that the majority of patients could read extra lines on the Jaeger chart after using the eye drops, and improvements were sustained for up to two years.
Researchers used AI to assess images of patients' eyes and predict those who needed prompt treatment, successfully sorting up to 90% of patients. The study's findings could lead to earlier treatment and reduced unnecessary monitoring for patients with keratoconus.
Two new studies show that cataract surgery on both eyes can be safe and effective for most patients to perform immediately after surgery, with high rates of independence and minimal need for assistance. Patients receiving multifocal lenses achieved the best visual outcomes, with over 85% achieving 20/20 vision or better.
A team of researchers has received funding to study the PRPH2 gene, crucial for normal vision, but when mutated causes a range of retinal diseases leading to blindness. They aim to uncover the underlying mechanisms of PRPH2-associated pathology to develop effective therapies.
Researchers at Seoul National University of Science and Technology developed a microelectrode with three-dimensional carbon nanotubes that efficiently conduct electricity while being soft like tissue. The arrays demonstrated stable insertion in brain tissues, precise recording of visual responses, and reduced inflammatory responses.
Researchers at Wayne State University are developing novel therapies to treat ocular chemical injuries using host-derived metabolites. The project aims to reduce inflammation, promote corneal nerve regeneration, and enhance wound healing, with potential for clinically translatable treatments that can preserve vision.
Researchers mapped fluid reservoir dynamics in scleral lens wear, finding rapid changes within the first two hours and regional asymmetry. The study emphasizes the need for comprehensive evaluation of peripheral corneal areas to ensure optimal lens fitting and ocular health.
Glaucoma is a leading cause of vision loss, with over 7.7 million people globally affected in 2020. The new microstent reduces excessive fluid buildup and intraocular pressure, supporting the eye's natural space and improving treatment efficacy. Its durable nickel-titanium alloy enables long-term safety and functionality.
Cohort study finds GLP-1 receptor agonist use associated with modestly increased risk of incident diabetic retinopathy; however, those with preexisting DR experience fewer sight-threatening complications. Regular screening and monitoring recommended for all T2D patients on GLP-1 RAs.
A new study published in JAMA Network Open reveals that patients with type 2 diabetes prescribed semaglutide or tirzepatide are at increased risk of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders. The overall risk is low, but highlights the need for close monitoring of these conditions.
Researchers have established apple snails as a system to study eye regeneration, which may hold the key for restoring vision due to damage and disease. The team discovered that the snail eye is anatomically similar to humans and can regrow itself, with genes such as pax6 playing a crucial role in development.
In a breakthrough study, researchers at the University of Rochester Medical Center found that microglia cells respond differently than neutrophils to photoreceptor damage in the retina. This discovery has high implications for treating vision loss caused by photoreceptor cell damage.
A new route of delivering gene therapy is being explored, potentially reducing invasiveness and increasing accessibility. Researchers will test a novel approach on non-human primates, aiming to expand access to office-based treatments.
Scientists have identified a potential treatment strategy for ADOA by targeting the SARM1 protein, which triggers axon degeneration in retinal ganglion cells. Deleting or disabling SARM1 preserves RGCs and maintains vision in a mouse model.
Researchers created a new way to measure short-sightedness that better predicts long-term risk of serious retinal damage. The approach uses routine eye scans and AI to identify individuals at higher risk, who may require more tailored management to prevent vision loss.
A UCL-led study suggests that community-based technician-led virtual review clinics could significantly reduce wait times for patients with stable chronic eye conditions. The research found that appointment delays decreased by an average of 8.1 days per week after the clinic's launch, leading to a faster reduction in waiting times.
Researchers found that rod bipolar cells can form new functional connections with cones when their usual partners stop working in retinitis pigmentosa. This adaptation mechanism could reveal new targets for treatments aimed at preserving vision.
Researchers have identified a previously unknown organelle called the hemifusome that plays a crucial role in cellular sorting and recycling. This discovery could lead to targeted treatments for complex genetic disorders like Hermansky-Pudlak syndrome, which affects multiple systems in the body.
A new study found that increasing apolipoprotein M levels can slow or block progression of age-related macular degeneration, a leading cause of blindness in people over 50. The researchers also found that ApoM triggers a signaling pathway that breaks down cholesterol deposits.
A recent study published in The American Journal of Pathology has discovered that ADAM10 regulates abnormal blood vessel growth in the retina, which can cause vision loss or impairment. The findings suggest that targeting ADAM10 or its downstream effectors, such as Ephrin B2, may offer novel strategies for managing or preventing retina...
Scientists have discovered that heparan sulfate in Bruch's membrane traps lipoproteins, leading to drusen formation and vision loss. Targeting this interaction may prevent or reverse early signs of AMD.
The New York Eye and Ear Infirmary of Mount Sinai has opened a comprehensive center for refractive solutions, providing innovative treatment options for patients requiring refractive correction. The center offers streamlined care for premium cataract and corneal refractive procedures, including LASIK and custom LASIK.
A wearable device developed by researchers in Brazil uses a camera and tactile signals to warn visually impaired users of obstacles above the waistline. The device was tested on 11 blind adults and showed promising results, with participants reporting feeling more secure and completing routes with ease.
The University of Colorado Anschutz Medical Campus has received a historic $40 million gift to support research into treating and curing serious eye diseases like macular degeneration and glaucoma. The gift will also enable the development of new technologies and recruit top talent.
A new study by Anglia Ruskin University found that global refractive correction rates are at 65.8%, six percentage points lower than in 2010, and urge urgent action to meet the WHO's target of a 40% increase by 2030.
Researchers at the University of Pennsylvania developed novel promoters that drive specific gene expression in rod and cone photoreceptors, outperforming most currently used promoters. These tools address the challenge of treating advanced stages of inherited retinal diseases, potentially restoring vision.
A new low-cost, diode-based laser system safely emulsifies cataract tissue without damaging surrounding tissue. The technology has the potential to significantly reduce cataract surgery costs and complexity, bringing sight-saving treatment to millions worldwide.
A recent study found that mildly elevated eye pressure can distort blood vessels and lead to oxygen deficit in the eye. Researchers used 3D modeling and fluorescent dye to investigate how ocular hypertension affects the eye, revealing a potential new method for diagnosing glaucoma earlier.
The USPSTF recommends early, universal screening for syphilis infection during pregnancy to prevent congenital syphilis. Untreated syphilis can cause premature birth, low birth weight, and stillbirth in the fetus.
Researchers at Wayne State University are developing a new treatment to prevent diabetic corneal complications, which can lead to vision loss and poor healing. The project combines two naturally occurring peptides to target inflammation, delayed healing, and nerve degeneration.
A study by Dr. LEE Seung-Hee reveals how the brain dynamically adjusts sensory input prioritization depending on movement, with vision taking priority for navigation. The posterior parietal cortex and secondary motor cortex play key roles in this process.
A study found that patients with diabetes who recognize ophthalmology consultation recommendations are twice as likely to undergo a fundus examination. Individuals who recognized the recommendation were also more likely to understand the recommended frequency of ophthalmology visits.
A study published in the Archives of Gerontology and Geriatrics Plus found that the prevalence of older Americans without disabilities increased from 61% in 2008 to 65% in 2017. This represents a significant improvement, with an additional 2.07 million older Americans potentially having had disabilities if trends had remained constant.
A new study has identified genetic and demographic factors that increase the risk of developing age-related macular degeneration (AMD). The research found a significant difference in AMD risk between European and non-European descent populations, highlighting the importance of diverse ancestry groups in understanding this condition.
A new shape-changing device called Shape has been developed to help people with visual impairment perform a location task as effectively as sighted people. The study found that participants with visual impairment located targets significantly faster using Shape than with vibration technology, and preferred it over current methods.
A $6 million grant from the California Institute for Regenerative Medicine is driving research into a new treatment for dry age-related macular degeneration, a leading cause of blindness in older adults. The therapy aims to halt or reverse disease progression using stem cell-derived healthy retinal pigment epithelium cells.
A team of researchers has identified a mechanism that interferes with the splicing process in a more subtle way, leading to cell death. The study reveals that spliceosome subunits U4, U5, and U6 are normally stabilized by protein USP39, but when mutated or absent, stability is compromised, causing incorrect connections during splicing.
WorldScribe, a new software, uses generative AI to provide real-time text and audio descriptions of surroundings for people who are blind or have low vision. The tool can adjust the level of detail based on user commands or camera frame time.
Researchers have developed two smartphone apps that provide safe indoor navigation, route guidance, and return to a previous location. The apps use built-in sensors, such as accelerometers and gyroscopes, to track the user's progress, reducing reliance on visual cues.
Researchers at Arizona State University have developed new diagnostic tools using artificial intelligence (AI) to help identify myopic maculopathy, a serious eye condition. The AI-powered systems can analyze retinal images and predict the correct classification of the disease, enabling more accurate treatment recommendations.
A case report describes a woman who experienced bilateral blurry vision after using hair dye with aromatic amines. The incident highlights the potential risk of retinopathy associated with certain hair dyes.
Researchers have introduced DSFN to improve the speed and accuracy of diagnoses of retinal disorders. This AI-powered medical imaging technique combines retina images with vascular distribution information to accurately locate the fovea in complex clinical scenarios, enabling doctors to detect early signs of ocular diseases.
A study published in Neuron reveals that neurons are wired to connect seemingly unrelated concepts, enhancing the brain's ability to predict what we see based on past experiences. Visual experience influences the organisation of feedback projections, which store information about the world.
Researchers at UCL and Moorfields Eye Hospital have identified biomarkers that predict which patients with glaucoma are at higher risk of continued vision loss despite conventional treatment. Mitochondrial function in white blood cells is lower in people with glaucoma, leading to faster vision loss.
A new AI model has been developed to improve clinical trial recruitment for eye disease, specifically Geographic Atrophy. The system identified almost twice as many candidates and with higher precision compared to conventional approaches, showing promise for overcoming a major obstacle in GA clinical trials.
Researchers have found a pioneering approach to combat age-related vision loss with a new therapy that boosts IRAK-M levels in retinal cells. The discovery offers a comprehensive treatment option for the millions of people affected by AMD.
Researchers at the University of East Anglia have developed a novel resin for 3D printing intraocular devices, offering unprecedented levels of customization and design precision. This innovation has potential to enhance eye care globally with tailored lenses, faster production, and cost reduction.
A team of researchers from Tokyo Medical and Dental University developed a novel kind of optical coherence tomography (OCT) to investigate the detailed structure of the sclera in living patients. They found that the sclera is divided into inner and outer layers with different structural arrangements, which can provide important insight...
Researchers identified a spectrum of effects on sodium channel function due to SCN2A variants, with hyperactive channels linked to early seizure onset and underactive channels associated with autism. The study provides insights into the relationship between genetic changes, disease severity, and age of seizure onset.
A study led by the University of Cambridge found that AI models like GPT-4 outperformed doctors in diagnosing and treating eye problems. The researchers suggest using AI for triaging patients and providing advice in well-controlled contexts, where access to specialist healthcare professionals is limited.
A groundbreaking study reveals that targeting cholesterol metabolism can mitigate Zika virus-induced ocular pathology, offering promising therapeutic strategies. Researchers identified ABCG1 and SREBP-2 as key players in the pathway, and treatments with LXR agonists or SREBP-2 inhibitors showed promise in animal models.
A new AI technology has been developed to detect severe cases of retinopathy of prematurity (ROP) with 100% accuracy. The system analyzes retinal images and can identify blood vessel anomalies, enabling early treatment and potentially saving sight for thousands of premature infants globally.
The latest American Psychiatric Association journals feature new treatments across the lifespan for anxiety, depression, and substance use disorder. The March issue of The American Journal of Psychiatry highlights several studies with these findings.
Researchers at the Netherlands Institute for Neuroscience have developed an open-source visual prosthesis simulator to explore the potential of brain-computer interfaces. The simulator allows users to test simulated phosphene vision, which can help bridge the gap between hardware limitations and desired functionalities.
A new American Heart Association scientific statement offers the latest knowledge on neurodevelopmental outcomes in people of all ages with congenital heart disease. The statement highlights that neurodevelopmental difficulties are common complications faced by individuals with congenital heart disease, affecting their ability to funct...
The study reveals that the superior colliculus is vital in the transition from seeing individual flashes to smooth motion, and may be a key component in creating the continuity illusion. Different methods of measuring the Flicker Fusion Frequency threshold suggest other parts of the brain also play a role in this process.